Yahoo
OTC Markets OTCPK - Delayed Quote USD

Acutus Medical, Inc. (AFIB)

0.0001 0.0000 (0.00%)
As of October 30 at 5:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for AFIB
  • Previous Close 0.0001
  • Open 0.0005
  • Bid 0.0304 x --
  • Ask 0.0410 x --
  • Day's Range 0.0005 - 0.0005
  • 52 Week Range 0.0001 - 0.0140
  • Volume 10,000
  • Avg. Volume 3,353
  • Market Cap (intraday) 2,991
  • Beta (5Y Monthly) 5.95
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1500
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

www.acutusmedical.com

85

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AFIB
50.00%
S&P 500 (^GSPC)
10.69%

1-Year Return

AFIB
66.67%
S&P 500 (^GSPC)
10.59%

3-Year Return

AFIB
99.98%
S&P 500 (^GSPC)
73.86%

5-Year Return

AFIB
100.00%
S&P 500 (^GSPC)
62.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY23
Revenue 5.24M
Earnings -13.24M
Profit Margin -252.71%

Q4

FY22

Q1

FY23

Q2

FY23

Q3

FY23

-10M
0
10M
-200.0%
0.0%
200.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.36%

  • Return on Assets (ttm)

    -14.26%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    20.16M

  • Net Income Avi to Common (ttm)

    -4.54M

  • Diluted EPS (ttm)

    -0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.02M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -6.78M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: